USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 22.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 19.10.2026 | 19.10.2026 | Corebridge Financial, Inc. | Nippon Life Insurance Co. | 10% Owner | Kauf | 5.591.237,61 USD |
| 19.10.2026 | 19.10.2026 | J.JILL, Inc. | Mark W. Webb | EVP, CFO & COO | Verkauf | 122.600,00 USD |
| 19.10.2026 | 19.10.2026 | MSD Investment Corp. | Brian S. Williams | See Remarks | Kauf | 310.906,58 USD |
| 19.10.2026 | 19.10.2026 | Global X Venture & Innovation Fund | Global X Management Company, Inc. | 10% Owner | Kauf | 25.000.000,00 USD |
| 19.10.2026 | 19.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 13.800,00 USD |
| 19.10.2026 | 19.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 24.150,00 USD |
| 19.10.2026 | 19.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 1.150,00 USD |
| 19.10.2026 | 19.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 16.100,00 USD |
| 19.10.2026 | 19.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 71.300,00 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 98.885,88 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 564.660,81 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 55.177,36 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 82.589,76 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 471.653,91 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 46.069,90 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 353.992,68 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 2.021.377,89 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 197.461,45 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 9.527,40 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 54.379,71 USD |
| 19.10.2026 | 20.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 5.326,00 USD |
| 19.10.2026 | 19.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 360.884,34 USD |
| 19.10.2026 | 19.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 301.408,62 USD |
| 19.10.2026 | 19.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 1.291.818,96 USD |
| 19.10.2026 | 19.10.2026 | Alamar Biosciences, Inc. | Qiming Corporate GP VI, Ltd. | 10% Owner | Verkauf | 34.768,80 USD |
| 19.10.2026 | 21.10.2026 | Bluerock Private Real Estate Fund 🔥 Cluster | Ramin Kamfar | Director | Kauf | 1.407.600,89 USD |
| 19.10.2026 | 20.10.2026 | Bluerock Private Real Estate Fund 🔥 Cluster | Ramin Kamfar | Director | Kauf | 1.143.957,28 USD |
| 19.10.2026 | 19.10.2026 | Bluerock Private Real Estate Fund 🔥 Cluster | Ramin Kamfar | Director | Kauf | 793.448,00 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 2.019.168,45 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 4.631.185,72 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 12.506.902,88 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 26.156.811,20 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 21.628.969,82 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 12.896.144,64 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 7.157.378,54 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 1.329.638,00 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 3.736.003,56 USD |
| 19.10.2026 | 19.10.2026 | Snowflake Inc. | Frank Slootman | Director | Verkauf | 2.867.973,20 USD |
| 19.10.2026 | 19.10.2026 | Heritage Insurance Holdings, Inc. | Timothy E. Johns | See Remarks | Verkauf | 125.685,70 USD |
| 19.10.2026 | 19.10.2026 | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | Kauf | 8.001,28 USD |
| 19.10.2026 | 19.10.2026 | Mara Holdings, Inc. | Salman Hassan Khan | Chief Financial Officer | Verkauf | 126.080,00 USD |
| 19.10.2026 | 21.10.2026 | Star Equity Holdings, Inc. | Jeffrey E. Eberwein | Chief Executive Officer / Director / 10% Owner | Verkauf | 8.990,00 USD |
| 19.10.2026 | 20.10.2026 | Star Equity Holdings, Inc. | Jeffrey E. Eberwein | Chief Executive Officer / Director / 10% Owner | Verkauf | 9.100,00 USD |
| 19.10.2026 | 19.10.2026 | Star Equity Holdings, Inc. | Jeffrey E. Eberwein | Chief Executive Officer / Director / 10% Owner | Verkauf | 9.110,00 USD |
| 19.10.2026 | 20.10.2026 | Pagseguro Digital Ltd. | Alexandre Mr Magnani | Director | Verkauf | 528.273,60 USD |
| 19.10.2026 | 19.10.2026 | Pagseguro Digital Ltd. | Alexandre Mr Magnani | Director | Verkauf | 181.265,25 USD |
| 19.10.2026 | 19.10.2026 | Intapp, Inc. | John T. Hall | Chief Executive Officer / Director | Verkauf | 124.312,44 USD |
| 19.10.2026 | 19.10.2026 | Intapp, Inc. | John T. Hall | Chief Executive Officer / Director | Verkauf | 8.730,00 USD |
| 19.10.2026 | 21.10.2026 | Disc Medicine, Inc. | Kevin Bitterman | Director | Verkauf | 21.341,18 USD |
| 19.10.2026 | 21.10.2026 | Disc Medicine, Inc. | Kevin Bitterman | Director | Verkauf | 920.238,10 USD |